Researching: GLP-1
Pulling real-time news, deal activity, and upcoming catalysts
Analyzing sources for "GLP-1"...
RxInsider Coverage (10)
The Week
Lilly covers lifelong obesity journey in new GLP-1 Medicaid access campaign
Aug 25
The Week
Roche outlays $2.3bn for Hanmi's non-GLP-1 obesity candidate
Aug 24
The Week
How cost and perception could reshape the GLP-1 market
Aug 21
The Week
How cost and perception could reshape the GLP-1 market
Aug 19
The Week
STAT+: A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass
Aug 18
The Week
The Oral GLP-1 Tracker: Lilly's Foundayo builds scripts after disappointing Q2
Aug 9
The Week
Psychedelics, peptides and GLP-1s: the signals behind FiercePharma’s weekly watchlist
Aug 1
The Week
Eli Lilly tops new biopharma ranking on launch success, development speed
Jul 29
The Week
Compounders maintain a firm grip on the GLP-1 market
Jul 17
The Week
The Oral GLP-1 Tracker: Lilly's Foundayo launch remains 'muted'
Jul 11
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.